1082041-90-4 Usage
Description
5-Bromo-4-chloro-1H-indazole is a heterocyclic aromatic chemical compound with the molecular formula C7H4BrClN2. It is widely utilized in pharmaceutical research as a key building block for the synthesis of biologically active compounds. Known for its potential as an anti-inflammatory and analgesic agent, this compound also serves as a precursor in the production of various pharmaceutical drugs. Due to its classification as a hazardous chemical, it requires careful handling to mitigate any potential health risks.
Uses
Used in Pharmaceutical Research:
5-Bromo-4-chloro-1H-indazole is used as a building block for the synthesis of biologically active compounds, contributing to the development of new pharmaceuticals with diverse therapeutic applications.
Used in Anti-inflammatory and Analgesic Applications:
5-Bromo-4-chloro-1H-indazole is used as an anti-inflammatory and analgesic agent, potentially providing relief from inflammation and pain due to its pharmacological properties.
Used in Drug Manufacturing:
As a precursor in the manufacture of various pharmaceutical drugs, 5-Bromo-4-chloro-1H-indazole plays a crucial role in the production of medications that address a range of health conditions.
Used in Hazardous Chemical Handling:
5-Bromo-4-chloro-1H-indazole, classified as a hazardous chemical, necessitates the implementation of proper handling and safety measures to prevent any adverse health effects on individuals who come into contact with it.
Check Digit Verification of cas no
The CAS Registry Mumber 1082041-90-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,2,0,4 and 1 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1082041-90:
(9*1)+(8*0)+(7*8)+(6*2)+(5*0)+(4*4)+(3*1)+(2*9)+(1*0)=114
114 % 10 = 4
So 1082041-90-4 is a valid CAS Registry Number.
1082041-90-4Relevant articles and documents
4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF
-
Paragraph 0412, (2021/05/07)
The present invention provides an antitumor agent comprising a compound or a pharmaceutically acceptable salt thereof that covalently binds to GTP-bound KRASG12C as an active ingredient.
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
-
Page/Page column 56-57, (2012/04/04)
Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
